Lilly at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Lilly exhibits at Booth 1039 at ASH 2026 in New Orleans. Its presence centres on chronic lymphocytic leukemia, supporting symposia on treatment order after relapse, patient priorities and differing expert approaches. It also supports a symposium on BTK inhibitor options and new targeted strategies in mantle cell lymphoma.
| Organization | ASH 2026 Attendance |
|---|---|
Lilly Indianapolis, IN | |
Global pharmaceutical company based in Indianapolis whose oncology portfolio includes the BTK inhibitor pirtobrutinib for CLL and mantle cell lymphoma. | Booth Exhibiting at Booth 1039 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00pm–10:00pm Cases and Conversations: Sequencing Strategies in Relapsed and Refractory CLL Continuous kinase inhibitors versus fixed-duration Bcl-2 combinations for chronic lymphocytic leukemia, weighed against recent phase 3 trial results. Symposium Fri Dec 11 11:00am–2:00pm CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies Shared decision-making in chronic lymphocytic leukemia, using biomarker testing to choose among fixed-duration, continuous, and newer targeted treatments. Symposium Fri Dec 11 7:00am–10:00am Consensus or Controversy? Documenting And Discussing Investigators’ Approaches to the Management of Patients with Chronic Lymphocytic Leukemia How clinical investigators differ on managing chronic lymphocytic leukemia, comparing their answers on hard cases alongside current data and ongoing research. Symposium Fri Dec 11 11:00am–2:00pm Realigning Modern Care in MCL: Guidance on the Next Wave of Advances With BTK Inhibitor Options and New Targeted Strategies Mantle cell lymphoma care built on Bruton tyrosine kinase inhibitors up front, with newer kinase and Bcl-2 inhibitors or CAR-T after relapse. |
Instantly find 20 buyers from Lilly
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction